Polymer Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
VPM
VCM
QCM
Polymer Capital Management's NVCR Position: Q1 2026 in Review
Polymer Capital Management sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 13,625 shares — an estimated $176K sold.
Polymer Capital Management first reported a position in NVCR in Q4 2024 and held it in 2 quarters. The position peaked at $208K in Q4 2024. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- Polymer Capital Management reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
- Polymer Capital Management sold 13,625 NovoCure shares in Q1 2026, an estimated $176K.
- Polymer Capital Management first reported a position in NovoCure in Q4 2024 and held it in 2 quarters.
- Polymer Capital Management's NovoCure position peaked at $208K in Q4 2024.
- 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.